Pasithea Therapeutics - Warrants (11/08/2026) Total Assets

As of the most recent data (March 2026), KTTAW shows a total assets of $56B. That compares with $15B in the prior-year period — up 284.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KTTAW's total assets is now $56B (was $15B) — a 284.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pasithea Therapeutics - Warrants (11/08/2026) is outperforming or lagging.

Tracking KTTAW's total assets over time shows whether Pasithea Therapeutics - Warrants (11/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $56B That compares with $15B in the prior-year period — up 284.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Pasithea Therapeutics - Warrants (11/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $56B) with ownership activity and broader fundamentals.

Pasithea Therapeutics - Warrants (11/08/2026)'s total assets is $56B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.